Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY18.46 CNY
Change Today +0.58 / 3.24%
Volume 23.7M
As of 2:30 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - shanghai pharmaceuticals-a (601607)

Name (Connections)Board RelationshipsTitleKey Developments
Cho Che Tse 11 RelationshipsIndependent Non-Executive Director, Convener of Nomination Committee, Member of Strategy Committee and Member of Audit Committee 
Kam To Wan 105 RelationshipsIndependent Non-Executive Director, Convener of Audit Committee and Member of Remuneration & Assessment Committee 

Compensation Committee* - shanghai pharmaceuticals-a (601607)

Name (Connections)Board RelationshipsTitle
Zhenfu Li 11 RelationshipsIndependent Non-Executive Director, Member of Remuneration & Assessment Committee and Member of Strategy Committee
Kam To Wan 105 RelationshipsIndependent Non-Executive Director, Convener of Audit Committee and Member of Remuneration & Assessment Committee
601607 Compensation vs. Industry
906.0K
472.4K
Chief Executive Officer
Share price activity for SHANGHAI PHARMACEUTICALS-A (601607)
52 Week Price Performance
601607
Industry Average

Nominating Committee* - shanghai pharmaceuticals-a (601607)

Name (Connections)Board RelationshipsTitleKey Developments
Dingbo Lou 30 RelationshipsChairman, Convener of Strategy Committee and Member of Nomination CommitteeShanghai Pharmaceuticals Holding Co., Ltd. Announces Executive Changes
08/10/15
Cho Che Tse 11 RelationshipsIndependent Non-Executive Director, Convener of Nomination Committee, Member of Strategy Committee and Member of Audit CommitteeShanghai Pharmaceuticals Holding Co., Ltd. Approves the Appointment of Hu Fengxiang to the Board of Directors; Approves Dividend for Year 2012, Payable on or Around July 30, 2013
06/5/13
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
601607:CH CNY18.46 CNY +0.58

601607 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Huadong Medicine Co Ltd CNY74.80 CNY +2.00
Jointown Pharmaceutical Group Co Ltd CNY17.42 CNY +1.17
Nanjing Pharmaceutical Co Ltd CNY8.80 CNY +0.59
Wanjia Group Holdings Ltd $0.64 HKD +0.10
View Industry Companies
 

Industry Analysis

601607

Industry Average

Valuation 601607 Industry Range
Price/Earnings 15.9x
Price/Sales 0.5x
Price/Book 1.5x
Price/Cash Flow 11.3x
TEV/Sales 0.1x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHANGHAI PHARMACEUTICALS-A, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.